Page 2 - Best Larynx cancer doctors in Turkey: TOP 31 doctors

Assoc. Prof. Nail Paksoy brings extensive oncology expertise to Medipol Bahçelievler Hospital, with a focus on larynx cancer treatment.

• ESMO Board Certified in Medical Oncology
• Participated in 8 international clinical trials as subinvestigator
• Published multiple studies on cancer treatment outcomes
• Specialized training at Istanbul University Oncology Institute

Dr. Ismail Ozdemir specializes in Ear, Nose, Throat, and Head and Neck Surgery with decades of experience in complex cases.

• Graduated from Hacettepe University Eskisehir Medical Faculty
• Served as ENT specialist in multiple prestigious hospitals
• Former head of ENT department at Namik Kemal University
• Extensive experience in surgical medical education

Professor Doctor Sefik Igdem specializes in radiation oncology, focusing on head and neck cancers at Gayrettepe Florence Nightingale Hospital.

• Over 25 years of experience in radiation oncology
• Expert in conformal treatments and advanced technologies like Truebeam Stx
• Professor at T.R Demiroğlu Bilim University
• Trained at Istanbul University Cerrahpaşa Faculty of Medicine

Dr. Topcu specializes in treating larynx cancer among various other cancers, with extensive training at renowned international cancer centers.

• Trained at MD Anderson Cancer Center and Sunnybrook Odette Cancer Center
• Specialized in Medical Oncology from Karadeniz Technical University
• Experienced in treating a wide range of cancers including head and neck cancers
• Works at Valued Med Hub Hospitals

Dr. Topcu brings international expertise from MD Anderson and Sunnybrook Odette Cancer Center to larynx cancer care at Biruni University Hospital.

• Specializes in head and neck cancers including larynx cancer
• Trained at top institutions in the US and Canada
• Member of ESMO and ASCO – leading oncology societies
• Over 15 years of experience in medical oncology

Dr. Ercan Ozden specializes in medical oncology with extensive experience in treating larynx cancer and improving patient outcomes.

• Over 20 years of experience in internal medicine and oncology
• Completed medical oncology subspecialty at Kocaeli University Faculty of Medicine
• Skilled in comprehensive treatment planning for laryngeal malignancies
• Fluent in English and Turkish, ensuring clear communication with international patients

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Specialist Dr. Rahib Hasanov brings international expertise from Houston Methodist Hospital and focuses on personalized oncology treatments like immunotherapies and targeted therapies.

• Trained at Istanbul University Cerrahpaşa and Marmara University
• Specializes in gastrointestinal, urogenital, and breast cancers
• Incorporates smart drugs and modern treatment methods
• Treats patients from multiple countries, including Europe and the US

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.